Imperial College London

Prof. William Wisden F. Med. Sci.

Faculty of Natural SciencesDepartment of Life Sciences

Chair in Molecular Neuroscience
 
 
 
//

Contact

 

+44 (0)20 7594 9744w.wisden Website CV

 
 
//

Location

 

401BSir Ernst Chain BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Korpi:1997,
author = {Korpi, ER and Wisden, W and Lüddens, H},
journal = {Lakartidningen},
pages = {3403--3408},
title = {[Better cure for anxiety, sleep disorders, epilepsy?].},
url = {https://www.ncbi.nlm.nih.gov/pubmed/9379810},
volume = {94},
year = {1997}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Gamma-aminobutyric acid (GABA), the most important inhibitory neurotransmitter, is characterised by rapid effects that are mediated via GABAA, receptors. These receptors are also targets for many drugs including benzodiazepines, barbiturates and general anaesthetics. Recognition of the heterogeneity of GABAA receptors has opened up new possibilities for the development of more selective therapeutic agents. In particular, subtype-specific receptor ligands varying in intrinsic activity are likely to give rise to fewer side effects than do currently available drugs.
AU - Korpi,ER
AU - Wisden,W
AU - Lüddens,H
EP - 3408
PY - 1997///
SN - 0023-7205
SP - 3403
TI - [Better cure for anxiety, sleep disorders, epilepsy?].
T2 - Lakartidningen
UR - https://www.ncbi.nlm.nih.gov/pubmed/9379810
VL - 94
ER -